Last edition
News about "AI in Drug Discovery"
TDB-DST Backs Peptris with INR 86 Crore for AI Drug Discovery
TDB-DST has partnered with Peptris to provide INR 86 crore in RDI support for AI-driven drug discovery, advancing 4 drug candidates toward clinical development.
AI In Drug Discovery | 13/10/2026 | By News Bureau
QIAGEN Expands AI Bioinformatics for Research and Drug Discovery
QIAGEN expands AI-powered bioinformatics with IPA Investigator, enabling researchers to ask biological questions in natural language and explore scientific evidence.
AI In Drug Discovery | 07/10/2026 | By News Bureau
Union MoS Anupriya Patel Calls for India to Become Laboratory of the World
Union Minister of State (MoS) Anupriya Patel urges India to become the ‘Laboratory of the World’ as IIM-A Healthcare Summit 2026 explores Artificial Intelligence (AI)-driven drug discovery and healthcare.
AI In Drug Discovery | 24/08/2026 | By News Bureau | 121
Bristol Myers Squibb Partners with NVIDIA to Build AI Factory
Bristol Myers Squibb and NVIDIA are building an Artificial Intelligence (AI) factory to accelerate drug discovery using advanced AI infrastructure and proprietary life sciences models.
AI In Drug Discovery | 22/07/2026 | By News Bureau | 147
Owkin and Sanofi Partner to Develop AI Agents for Drug Discovery
Owkin and Sanofi have expanded their multi-year K Pro collaboration to develop AI agents that enhance drug discovery and development. By integrating agentic AI systems into research workflows, the partnership aims to unlock the full value of data, improve decision-making, and accelerate the development of innovative therapies.
AI In Drug Discovery | 06/06/2026 | By News Bureau | 360
Tempus Launches Next-Generation Lens AI Platform for Oncology Drug Development
Tempus has unveiled the next-generation Lens platform, expanding its agentic AI capabilities for oncology drug development by leveraging over a decade of longitudinal real-world data and advanced analytics to generate actionable insights for biopharma research, clinical development, and precision medicine.
AI In Drug Discovery | 01/06/2026 | By News Bureau | 592
Harbour BioMed Reports Promising Preclinical Data for AI-Driven Drug Candidate LET003
Harbour BioMed announced promising preclinical data for LET003, its first Artificial Intelligence (AI)-enabled drug candidate, highlighting potential as a next-generation obesity therapy targeting ACVR2A/2B.
AI In Drug Discovery | 18/05/2026 | By News Bureau | 377
BioMed X Launches First Research Team in France to Advance AI-Driven Antibody Design
BioMed X launches AI-focused antibody research team in France, aiming to accelerate development of next-generation biologic therapies for cancer and immune diseases.
AI In Drug Discovery | 21/04/2026 | By News Bureau | 193
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy